Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0UY9Y
|
|||
Drug Name |
PMID25991433-Compound-P2
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H14N2O3S
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)CC(=O)NC2=C(SC=C2)C3=NC=CO3
|
|||
InChI |
1S/C16H14N2O3S/c1-20-12-4-2-11(3-5-12)10-14(19)18-13-6-9-22-15(13)16-17-7-8-21-16/h2-9H,10H2,1H3,(H,18,19)
|
|||
InChIKey |
KSZHRLGDJPCAID-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [1] |
Target's Patent Info | Mitogen-activated protein kinase (MAPK) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.